Even individuals whose symptoms do not yet meet the criteria for clinical depression benefit from therapeutic interventions. This conclusion comes from a new meta-study by researchers who analyzed ...

The well-funded biotech lost most of its value after its drug flunked a late-stage trial. One analyst described the results ...

"But some people find different medication works better for them ... Jake Jake says the gym is a saviour for helping with his clinical depression Jake, who suffers with clinical depression ...

Neuroscience company Neumora Therapeutics (NMRA) announced today that its experimental treatment for depression, Navacaprant, ...

The new status follows the recent launch of Usona’s Phase 2 clinical ... resistant depression at Imperial College London in 2015. Notoriously used as a recreational psychoactive drug, psilocybin ...

Clinical trials showed the pill helped to significantly reduce depressive symptoms within three days. The effect of the medication was maintained at four weeks after the last dose, the FDA said.

Depression can affect anyone. It is common, and in many cases severe. These days, there are good treatments available, ...

Neuroscience company Neumora Therapeutics (NMRA) announced today that its experimental treatment for depression, Navacaprant, fell short of expectations in a late-stage clinical trial ...

Employees suffering with depression or anxiety are likely to experience ... and researchers in the disciplines of general practice, occupational medicine, health and safety, health and clinical ...

In late 2019, the company’s stock was trading above $150 and then crashed below $65 after the drug, then known as SAGE-217, failed in a clinical trial. Although a later study in 2021 showed positive ...

The European Clinical Guidelines for the Management of Depression in Palliative Care emphasises screening ... observational study in patients already under the care of palliative medicine services.